Skip to content
Operation Infinite Justice – Lifestyle
Author:
RiboX Therapeutics Ltd.
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
August 8, 2026